Manufacturers Life Insurance Company, The Allogene Therapeutics, Inc. Transaction History
Manufacturers Life Insurance Company, The
- $109 Billion
- Q4 2024
A detailed history of Manufacturers Life Insurance Company, The transactions in Allogene Therapeutics, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 484,715 shares of ALLO stock, worth $1.26 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
484,715
Previous 486,023
0.27%
Holding current value
$1.26 Million
Previous $1.36 Million
24.12%
% of portfolio
0.0%
Previous 0.0%
Shares
27 transactions
Others Institutions Holding ALLO
# of Institutions
176Shares Held
139MCall Options Held
75.8KPut Options Held
52.8K-
Tpg Gp A, LLC Fort Worth, TX18.7MShares$48.7 Million1.1% of portfolio
-
Black Rock Inc. New York, NY16.4MShares$42.8 Million0.0% of portfolio
-
Lynx1 Capital Management LP San Juan, PR10.9MShares$28.3 Million9.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8MShares$20.8 Million0.0% of portfolio
-
State Street Corp Boston, MA7.25MShares$18.8 Million0.0% of portfolio
About Allogene Therapeutics, Inc.
- Ticker ALLO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 143,807,008
- Market Cap $374M
- Description
- Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...